These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23460941)

  • 41. Mutations in the motor and stalk domains of KIF5A in spastic paraplegia type 10 and in axonal Charcot-Marie-Tooth type 2.
    Crimella C; Baschirotto C; Arnoldi A; Tonelli A; Tenderini E; Airoldi G; Martinuzzi A; Trabacca A; Losito L; Scarlato M; Benedetti S; Scarpini E; Spinicci G; Bresolin N; Bassi MT
    Clin Genet; 2012 Aug; 82(2):157-64. PubMed ID: 21623771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of acrylamide and other sulfhydryl alkylators on the ability of dynein and kinesin to translocate microtubules in vitro.
    Martenson CH; Odom A; Sheetz MP; Graham DG
    Toxicol Appl Pharmacol; 1995 Jul; 133(1):73-81. PubMed ID: 7597712
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutations in dynein link motor neuron degeneration to defects in retrograde transport.
    Hafezparast M; Klocke R; Ruhrberg C; Marquardt A; Ahmad-Annuar A; Bowen S; Lalli G; Witherden AS; Hummerich H; Nicholson S; Morgan PJ; Oozageer R; Priestley JV; Averill S; King VR; Ball S; Peters J; Toda T; Yamamoto A; Hiraoka Y; Augustin M; Korthaus D; Wattler S; Wabnitz P; Dickneite C; Lampel S; Boehme F; Peraus G; Popp A; Rudelius M; Schlegel J; Fuchs H; Hrabe de Angelis M; Schiavo G; Shima DT; Russ AP; Stumm G; Martin JE; Fisher EM
    Science; 2003 May; 300(5620):808-12. PubMed ID: 12730604
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recruitment of dynein and kinesin to viral particles.
    Tati S; Alisaraie L
    FASEB J; 2022 May; 36(5):e22311. PubMed ID: 35471771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional analysis of mouse C-terminal kinesin motor KifC2.
    Yang Z; Roberts EA; Goldstein LS
    Mol Cell Biol; 2001 Apr; 21(7):2463-6. PubMed ID: 11259594
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of kinesin superfamily genes in cultured hippocampal neurons.
    Silverman MA; Kaech S; Ramser EM; Lu X; Lasarev MR; Nagalla S; Banker G
    Cytoskeleton (Hoboken); 2010 Dec; 67(12):784-95. PubMed ID: 20862690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential screening of mutated SOD1 transgenic mice reveals early up-regulation of a fast axonal transport component in spinal cord motor neurons.
    Dupuis L; de Tapia M; René F; Lutz-Bucher B; Gordon JW; Mercken L; Pradier L; Loeffler JP
    Neurobiol Dis; 2000 Aug; 7(4):274-85. PubMed ID: 10964600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly.
    Poirier K; Lebrun N; Broix L; Tian G; Saillour Y; Boscheron C; Parrini E; Valence S; Pierre BS; Oger M; Lacombe D; Geneviève D; Fontana E; Darra F; Cances C; Barth M; Bonneau D; Bernadina BD; N'guyen S; Gitiaux C; Parent P; des Portes V; Pedespan JM; Legrez V; Castelnau-Ptakine L; Nitschke P; Hieu T; Masson C; Zelenika D; Andrieux A; Francis F; Guerrini R; Cowan NJ; Bahi-Buisson N; Chelly J
    Nat Genet; 2013 Jun; 45(6):639-47. PubMed ID: 23603762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impairment of anterograde and retrograde neurofilament transport after anti-kinesin and anti-dynein antibody microinjection in chicken dorsal root ganglia.
    Theiss C; Napirei M; Meller K
    Eur J Cell Biol; 2005 Jan; 84(1):29-43. PubMed ID: 15724814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytoplasmic dynein conversion at a crush injury in rat peripheral axons.
    Li JY; Pfister KK; Brady ST; Dahlström A
    J Neurosci Res; 2000 Jul; 61(2):151-61. PubMed ID: 10878588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutations in cytoplasmic dynein and its regulators cause malformations of cortical development and neurodegenerative diseases.
    Lipka J; Kuijpers M; Jaworski J; Hoogenraad CC
    Biochem Soc Trans; 2013 Dec; 41(6):1605-12. PubMed ID: 24256262
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A human dynein heavy chain mutation impacts cortical progenitor cells causing developmental defects, reduced brain size and altered brain architecture.
    Romero DM; Zaidi D; Cifuentes-Diaz C; Maillard C; Grannec G; Selloum M; Birling MC; Bahi-Buisson N; Francis F
    Neurobiol Dis; 2023 May; 180():106085. PubMed ID: 36933672
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of dynein intermediate chains, light intermediate chains and light chains in a cohort of hereditary peripheral neuropathies.
    Tey S; Ahmad-Annuar A; Drew AP; Shahrizaila N; Nicholson GA; Kennerson ML
    Neurogenetics; 2014 Oct; 15(4):229-35. PubMed ID: 25028179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exome Sequencing Identifies De Novo DYNC1H1 Mutations Associated With Distal Spinal Muscular Atrophy and Malformations of Cortical Development.
    Chen Y; Xu Y; Li G; Li N; Yu T; Yao RE; Wang X; Shen Y; Wang J
    J Child Neurol; 2017 Mar; 32(4):379-386. PubMed ID: 28193117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. KIF5A de novo mutation associated with myoclonic seizures and neonatal onset progressive leukoencephalopathy.
    Rydzanicz M; Jagła M; Kosinska J; Tomasik T; Sobczak A; Pollak A; Herman-Sucharska I; Walczak A; Kwinta P; Płoski R
    Clin Genet; 2017 May; 91(5):769-773. PubMed ID: 27414745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis.
    Hares K; Kemp K; Rice C; Gray E; Scolding N; Wilkins A
    Mult Scler; 2014 Jun; 20(7):812-21. PubMed ID: 24144874
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The clinical-phenotype continuum in DYNC1H1-related disorders-genomic profiling and proposal for a novel classification.
    Becker LL; Dafsari HS; Schallner J; Abdin D; Seifert M; Petit F; Smol T; Bok L; Rodan L; Krapels I; Spranger S; Weschke B; Johnson K; Straub V; Kaindl AM; Di Donato N; von der Hagen M; Cirak S
    J Hum Genet; 2020 Nov; 65(11):1003-1017. PubMed ID: 32788638
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A hereditary spastic paraplegia mutation in kinesin-1A/KIF5A disrupts neurofilament transport.
    Wang L; Brown A
    Mol Neurodegener; 2010 Nov; 5():52. PubMed ID: 21087519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Computational prediction and analysis of deleterious cancer associated missense mutations in DYNC1H1.
    Sucularli C; Arslantas M
    Mol Cell Probes; 2017 Aug; 34():21-29. PubMed ID: 28455235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.